Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study

Children's Hospital Medical Center, Cincinnati · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
sickle-cell-disease
sickle cell disease, sickle cell anemia in children, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 885324
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.